Merck & Co. Inc.

NYS : MRK
Pharmaceuticals
Whitehouse Station New Jersey
2011 Revenue (US$ Millions)$48,047
2010 Revenue (US$ Millions)$45,987
Revenue Growth (%)4.48%
Net Income (US$ Millions)$6,272
Common Shares Outstanding (Millions)$3,041
Earnings Per Share (US$)$2.02
Earnings Per Share Growth (%)621.43%
Price To Earnings Ratio18.58
Total Equity (US$ Millions)$54,517
Profit Growth (%)628.46
Profit Margin (%)13.05%
Return On Equity (%)11.53%
Long Term Debt (US$ Millions)$15,525
Debt To Equity Ratio (%)0.28%
Market Capitalization (US$ Millions)$114,640
Total Assets (US$ Millions)$105,128
Return on Assets (%)5.93
Current Assets (US$ Millions)$33,181
Inventories (US$ Millions)$6,254
Current Liabilities (US$ Millions)$16,245
Cost of Goods Sold (US$ Millions)$16,871
Asset Turnover0.46
Inventory Turnover2.78